Low Expression of miR-20a-5p Predicts Benefit to...

Journal of Clinical Medicine 2020 / 06 Vol. 9; Iss. 6

Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial

Rinnerthaler, Gabriel, Gampenrieder, Simon Peter, Hackl, Hubert, Steiner, Markus, Monzo-Fuentes, Claudia, Melchardt, Thomas, Magnes, Teresa, Huemer, Florian, Westphal, Theresa, Hufnagl, Clemens, Hause
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Journal:
Journal of Clinical Medicine
DOI:
10.3390/jcm9061663
Date:
June, 2020
File:
PDF, 1.18 MB
2020
Conversion to is in progress
Conversion to is failed